Cell Programming Device Via Covalent Bonding or Ionic Bonding

Description

A method of modifying cells includes removing fluid including cells from a patient, contacting the removed fluid from the patient with at least one surface upon which at least one agent to interact at least one cell receptor is immobilized to modify cells in the fluid, and returning the fluid to the patient. The agent can, for example, be immobilized via covalent bonding or ionic bonding to the at least one surface. The fluid can, for example, be blood or a blood fraction. The agent can, for example, be an agonist, an antagonist or an inverse agonist.

IP Status

https://patents.google.com/patent/US10258734B2

Quick Facts:
Reference Number
02066
Technology Type
Medical Device
Technology Subtype
Therapeutic Medical Device
Therapeutic Areas
OncologyCardiovascular
Therapeutic Indications
Atherosclerotic disease
Tags
Regenerative medicinePlatform Technology
Lead Inventor
John Kellum
Department
Med-Critical Care Medicine
All Tech Innovators
William J. FederspielJohn A. Kellum JrKai Singbartl
Date Submitted
2009-08-29
Collections
Regenerative MedicineCardiometabolic